Metabolic Regulation of Caspases and Survival in T Cells
Caspases 的代谢调节和 T 细胞的存活
基本信息
- 批准号:9110491
- 负责人:
- 金额:$ 19.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:Autoimmune DiseasesAutoimmune ProcessCASP3 geneCaspaseCell DeathCell SurvivalComplexDown-RegulationElectron TransportEnvironmentFutureGenerationsGenus HippocampusGlycolysisHealthHumanImmune responseInfectionInflammatoryInterleukin-1 betaInterleukin-15Interleukin-2LinkMemoryMetabolicMetabolismMethylationMitochondriaModelingMouse ProteinMultiple SclerosisMusOligomycinsOxidative PhosphorylationPathogenesisPredispositionProtein MethylationProteinsPsoriasisReactive Nitrogen SpeciesReactive Oxygen SpeciesRegulationResearchResistanceRespirationRheumatoid ArthritisRoleRotenoneSeriesSiteSuggestionSyndromeSynovial FluidSynovial MembraneT memory cellT-Cell ProliferationT-LymphocyteTNF geneTestingTherapeuticTherapeutic InterventionTimeTissuesUlcerative Colitisautoreactive T cellcytokinedriving forceextracellularinhibitor/antagonistmitochondrial metabolismnovelprotein expressionresearch studyrheumatologisttissue culturetool
项目摘要
DESCRIPTION (provided by applicant): The survival of effector T cells to the memory state is more effective for those T cells undergoing mitochondrial oxidative phosphorylation (OxPhos) rather than glycolysis. IL-15 drives OxPhos in T cells and has been associated with several autoimmune disorders, such as rheumatoid arthritis, where the inflamed synovium is rich in IL-15. It is currently unknown how IL-15 promotes OxPhos in T cells or how this promotes T cell survival. Dr. Budd's and Rincon's groups have made two key preliminary observations that offer an explanation. First, Dr. Rincon has shown that a newly defined protein known as MCJ (Methylation- Controlled J protein) negatively regulates mitochondrial Complex I activity and OxPhos (6), Second, Dr. Budd has shown that IL-15 downregulates MCJ expression, allowing increased Complex I activity, elevated OxPhos and reactive radicals compared to IL-2-cultured T cells. This results in S-nitrosylation and S- glutathionylation and inactivation of caspase-3 at critical Cys163, which resides in the enzymatic pocket. This R21 application thus posits a novel hypothesis that IL-15 promotes effector T cell survival through downregulation of MCJ, resulting in enhanced mitochondrial OxPhos, reactive radicals, and inactivation of caspase-3 through S-nitrosylation. We then apply our murine findings to an actual human inflammatory condition rich in IL-15, rheumatoid synovium. Specific Aim 1 will determine whether retroviral re-expression of MCJ in IL-15-cultured T cells inhibits mitochondrial Complex I activity and OxPhos, and increases caspase-3 activity. We will then determine whether IL-15 also promotes supercomplex formation, as observed in MCJ-/- T cells. Specific Aim 2 will define whether IL-15 present in human rheumatoid synovium promotes OxPhos, ROS/RNS, reduced caspase-3 activity and resistance to cell death through MCJ downregulation. Rheumatoid synovial tissue or synovial fluid T cells will be assessed for their metabolic state by Seahorse flux analysis, ROS/RNS generation, MCJ levels, caspase-3 activity, and resistance to cell death. This novel study combines the expertise of the PI, a research rheumatologist, in regulation of caspases by cytokines in T cells, with those of Dr. Rincon who first described MCJ in T cells and its role in regulating mitochondrial respiration at Complex I. The findings would provide the framework for future expanded studies on the role of IL-15 and MCJ in immune responses and autoimmune disorders, such as rheumatoid arthritis. All the tools are in place to conduct these studies, including MCJ-/- mice and rheumatoid synovial tissue cultures. The experiments also represent a focused exploratory study with the potential for high yield for human inflammatory conditions and suggestions for therapeutic intervention through modulation of MCJ, IL-15, and metabolism.
描述(由申请人提供):效应T细胞与记忆状态的存活更为有效,对于那些接受线粒体氧化磷酸化(OXPHOS)而不是糖酵解的T细胞。 IL-15驱动T细胞中的Oxphos,并与几种自身免疫性疾病(例如类风湿关节炎)相关,其中发炎的滑膜在IL-15中富含IL-15。目前尚不清楚IL-15如何促进T细胞中的Oxphos或如何促进T细胞存活。 Budd's和Rincon博士的团体进行了两个关键的初步观察,提供了解释。首先,Rincon博士表明,新定义的称为MCJ(甲基化控制的J蛋白)负调节线粒体复合物I活性和Oxphos(6),其次,Budd博士表明IL-15降低MCJ表达,使IL-15的表达下调,允许IL-15的表达,使IL-15的IL-15下调,使IL的复杂I活性增加,氧气和反应性自由基与IL-2-Cult-cult-2-cult-culted t t t t t t te confectials iveption i活性。这会导致cys163处的caspase-3的S-亚硝基化和谷胱甘肽化和灭活,该caspase-3位于酶袋中。因此,这种R21的应用提出了一个新的假设,即IL-15通过下调MCJ促进效应T细胞的存活,从而导致线粒体oxphos,反应性自由基和通过S-硝基化的Caspase-3失活。然后,我们将鼠的发现应用于富含IL-15的类风湿滑膜的实际人类炎症状况。具体目标1将确定在IL-15培养的T细胞中MCJ的逆转录病毒重新表达是否抑制线粒体复合物I活性和OXPHOS,并增加caspase-3活性。然后,我们将确定IL-15是否还促进了MCJ - / - T细胞中观察到的超复合形成。特定的目标2将定义人类类风湿滑膜中存在的IL-15是否促进OXPHOS,ROS/RN,降低CASPASE-3活性以及通过MCJ下调对细胞死亡的耐药性。将通过海马通量分析,ROS/RNS产生,MCJ水平,caspase-3活性以及对细胞死亡的耐药性评估类风湿滑膜组织或滑液T细胞的代谢状态。 This novel study combines the expertise of the PI, a research rheumatologist, in regulation of caspases by cytokines in T cells, with those of Dr. Rincon who first described MCJ in T cells and its role in regulating mitochondrial respiration at Complex I. The findings would provide the framework for future expanded studies on the role of IL-15 and MCJ in immune responses and autoimmune disorders, such as rheumatoid关节炎。所有工具都可以进行这些研究,包括MCJ - / - 小鼠和类风湿滑膜组织培养物。该实验还代表了一项集中的探索性研究,具有通过调节MCJ,IL-15和代谢的调节,具有高收率的人类炎症条件和治疗干预的建议。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ralph C Budd其他文献
Ralph C Budd的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ralph C Budd', 18)}}的其他基金
Vermont Center for Immunobiology/Infectious Diseases (VCIID)
佛蒙特州免疫生物学/传染病中心 (VCIID)
- 批准号:
10395160 - 财政年份:2020
- 资助金额:
$ 19.3万 - 项目类别:
Vermont Immunobiology / Infectious Diseases Center
佛蒙特州免疫生物学/传染病中心
- 批准号:
10006835 - 财政年份:2016
- 资助金额:
$ 19.3万 - 项目类别:
VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTER
佛蒙特州免疫生物学/传染病中心
- 批准号:
8360768 - 财政年份:2011
- 资助金额:
$ 19.3万 - 项目类别:
VERMONT IMMUNOBIOL/INFECTIOUS DIS CTR: CORE A: ADMINISTRATIVE/INTELLECTUAL CORE
佛蒙特州免疫生物学/感染性疾病 CTR:核心 A:行政/智力核心
- 批准号:
8167727 - 财政年份:2010
- 资助金额:
$ 19.3万 - 项目类别:
VERMONT IMMUNOBIOL/INFECTIOUS DIS CTR: CORE A: ADMINISTRATIVE/INTELLECTUAL CORE
佛蒙特州免疫生物学/感染性疾病 CTR:核心 A:行政/智力核心
- 批准号:
7959813 - 财政年份:2009
- 资助金额:
$ 19.3万 - 项目类别:
Vermont Immunobiology / Infectious Diseases Center
佛蒙特州免疫生物学/传染病中心
- 批准号:
7906346 - 财政年份:2009
- 资助金额:
$ 19.3万 - 项目类别:
Gamma Delta T Cells in Lyme Arthritis
莱姆关节炎中的 Gamma Delta T 细胞
- 批准号:
7932685 - 财政年份:2009
- 资助金额:
$ 19.3万 - 项目类别:
Vermont Immunobiology / Infectious Diseases Center
佛蒙特州免疫生物学/传染病中心
- 批准号:
7892082 - 财政年份:2009
- 资助金额:
$ 19.3万 - 项目类别:
相似国自然基金
Setd2通过调控糖酵解过程促进树突状细胞活化启动1型糖尿病自身免疫应答的机制研究
- 批准号:82300929
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态对比增强联合分子靶向MRI可视化自身免疫性周围神经损伤及修复过程的实验研究
- 批准号:82302173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α-心脏肌球蛋白重链特异性T细胞在自身免疫性心肌炎致病过程中的作用及机制探讨
- 批准号:82000470
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
LC3相关的吞噬作用(LAP)对矽肺发展过程中矽尘诱发自身免疫性疾病的作用机制研究
- 批准号:81773376
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
自身免疫性胆管炎发病过程中NK细胞的免疫调节作用
- 批准号:81401336
- 批准年份:2014
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular mechanisms of gasdermin recognition by proteases and autophagy proteins in cytokine release
细胞因子释放中蛋白酶和自噬蛋白识别gasdermin的分子机制
- 批准号:
10024454 - 财政年份:2020
- 资助金额:
$ 19.3万 - 项目类别:
Regulation of the Cell Death Program by DFNA5
DFNA5 对细胞死亡程序的调节
- 批准号:
10531607 - 财政年份:2019
- 资助金额:
$ 19.3万 - 项目类别:
Evolution of effector caspase conformational landscapes
效应器半胱天冬酶构象景观的进化
- 批准号:
9902492 - 财政年份:2019
- 资助金额:
$ 19.3万 - 项目类别:
Regulation of the Cell Death Program by DFNA5
DFNA5 对细胞死亡程序的调节
- 批准号:
10307533 - 财政年份:2019
- 资助金额:
$ 19.3万 - 项目类别:
Evolution of effector caspase conformational landscapes
效应器半胱天冬酶构象景观的进化
- 批准号:
9927164 - 财政年份:2019
- 资助金额:
$ 19.3万 - 项目类别: